MESAROS; Eugen F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for MESAROS; Eugen F..The latest application filed is for "solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof".
- MESAROS; Eugen F. - Wallingford PA
| Patent | Date |
|---|---|
| Solid Forms Of An Orally-delivered Beta-lactamase Inhibitor And Uses Thereof App 20220194964 - BURNS; Christopher J. ; et al. | 2022-06-23 |
| Penicillin-binding protein inhibitors Grant 11,332,485 - Burns , et al. May 17, 2 | 2022-05-17 |
| Penicillin-binding protein inhibitors Grant 11,267,826 - Burns , et al. March 8, 2 | 2022-03-08 |
| Penicillin-binding Protein Inhibitors App 20210198288 - BURNS; Christopher J. ; et al. | 2021-07-01 |
| Penicillin-binding Protein Inhibitors App 20200157123 - BURNS; Christopher J. ; et al. | 2020-05-21 |
| Penicillin-binding Protein Inhibitors App 20200102331 - BURNS; Christopher J. ; et al. | 2020-04-02 |
| Beta-lactamase inhibitors Grant 10,464,952 - Burns , et al. No | 2019-11-05 |
| Azaquinazoline inhibitors of atypical protein kinase C Grant 10,414,763 - Dorsey , et al. Sept | 2019-09-17 |
| Beta-lactamase Inhibitors App 20180291039 - BURNS; Christopher J. ; et al. | 2018-10-11 |
| Azaquinazoline inhibitors of Atypical protein Kinase C Grant 9,914,730 - Breslin , et al. March 13, 2 | 2018-03-13 |
| Azaquinazoline inhibitors of atypical protein kinase C Grant 9,896,446 - Breslin , et al. February 20, 2 | 2018-02-20 |
| Pyrrolotriazines As Alk Inhibitors App 20160347756 - Haltiwanger; Ralph C. ; et al. | 2016-12-01 |
| Pyrrolotriazines as ALK inhibitors Grant 9,440,984 - Haltiwanger , et al. September 13, 2 | 2016-09-13 |
| Azaquinazoline Inhibitors of Atypical Protein Kinase C App 20160102094 - Breslin; Henry J. ; et al. | 2016-04-14 |
| Pyrrolotriazines As Alk Inhibitors App 20160068535 - Haltiwanger; Ralph C. ; et al. | 2016-03-10 |
| Azaquinazoline Inhibitors Of Atypical Protein Kinase C App 20150274720 - Dorsey; Bruce D. ; et al. | 2015-10-01 |
| Azaquinazoline Inhibitors of Atypical Protein Kinase C App 20140113882 - Breslin; Henry J. ; et al. | 2014-04-24 |
| Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,633,173 - Curry , et al. January 21, 2 | 2014-01-21 |
| Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20130296312 - Curry; Matthew A. ; et al. | 2013-11-07 |
| Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors Grant 8,552,186 - Ahmed , et al. October 8, 2 | 2013-10-08 |
| Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,501,936 - Curry , et al. August 6, 2 | 2013-08-06 |
| Pyrrolotriazines as ALK and JAK2 inhibitors Grant 8,471,005 - Breslin , et al. June 25, 2 | 2013-06-25 |
| Pyrrolotriazines As Alk And Jak2 Inhibitors App 20120028919 - Breslin; Henry J. ; et al. | 2012-02-02 |
| Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20100311693 - Curry; Matthew A. ; et al. | 2010-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 